123 results
Page 5 of 7
8-K
EX-10.1
rcfip 25jk
5 Feb 19
Entry into a Material Definitive Agreement
4:49pm
8-K
EX-10.1
hfrvgwsh5sifmh
20 Aug 18
VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development
12:00am
8-K
EX-10.1
6wby3f5qs
19 Jul 18
Entry into a Material Definitive Agreement
10:08am
8-K
EX-10.1
h08qop4
31 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
8zgquh38jzgn8o 4ptt
27 Oct 17
VBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5 Million
12:00am
8-K
EX-10.1
wiooe
2 Oct 17
Entry into a Material Definitive Agreement
12:00am
10-Q
EX-10.4
8qbkv5ep
15 May 17
Quarterly report
12:00am
8-K
EX-10.2
kqzl4og 5cgfoo5n
30 Mar 17
Entry into a Material Definitive Agreement
12:00am
10-K
EX-10.39
azxgb0p ceu
20 Mar 17
Annual report
12:00am
10-K
EX-10.40
abz5j db5b9lod0icre2
20 Mar 17
Annual report
12:00am
10-K
EX-10.1
cn18eg0d5w8xhlhjtsgk
20 Mar 17
Annual report
12:00am
10-K
EX-10.37
sjhmzqmg
20 Mar 17
Annual report
12:00am